General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

New investors

Welcome to Novartis

The Novartis new investor center is a resource intended to serve investors new to the Novartis story. Here, you can familiarize yourself with the company, learn about our growth strategy, meet the management team, and find information on key products commercially available and in our development pipeline. You can also review our past financial performance and find important information on how to invest in Novartis here. Of course, if you have any question you can contact a member of our investor relations team.

Get to know us. Here are helpful links to get you started.

Stock chart